跳到主要导航 跳到搜索 跳到主要内容

Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors

  • Chunwei Xu
  • , Yongchang Zhang
  • , Wenxian Wang
  • , Qian Wang
  • , Ziming Li
  • , Zhengbo Song
  • , Jiandong Wang
  • , Jinpu Yu
  • , Jingjing Liu
  • , Shirong Zhang
  • , Xiuyu Cai
  • , Ming Wu
  • , Ping Zhan
  • , Hongbing Liu
  • , Tangfeng Lv
  • , Liyun Miao
  • , Lingfeng Min
  • , Jiancheng Li
  • , Baogang Liu
  • , Jingping Yuan
  • Zhansheng Jiang, Gen Lin, Xiaohui Chen, Xingxiang Pu, Chuangzhou Rao, Dongqing Lv, Zongyang Yu, Xiaoyan Li, Chuanhao Tang, Chengzhi Zhou, Junping Zhang, Hui Guo, Qian Chu, Rui Meng, Xuewen Liu, Jingxun Wu, Xiao Hu, Min Fang, Jin Zhou, Zhengfei Zhu, Xiaofeng Chen, Weiwei Pan, Fei Pang, Yuxiang Zhou, Qijie Jian, Kai Wang, Liping Wang, Youcai Zhu, Guocai Yang, Xinqing Lin, Jing Cai, Lijun Liang, Huijing Feng, Lin Wang, Yingying Du, Wang Yao, Xuefei Shi, Xiaomin Niu, Dongmei Yuan, Yanwen Yao, Jianhui Huang, Yinbin Zhang, Pingli Sun, Hong Wang, Mingxiang Ye, Dong Wang, Zhaofeng Wang, Yue Hao, Zhen Wang, Bing Wan, Donglai Lv, Genhua Yu, Anna Li, Jin Kang, Jiatao Zhang, Chao Zhang, Huafei Chen, Lin Shi, Leiguang Ye, Gaoming Wang, Yina Wang, Feng Gao, Wei Zhou, Chunxiu Hu, Jianguo Wei, Bihui Li, Zhongwu Li, Yuan Li, Zhefeng Liu, Nong Yang, Lin Wu, Qiming Wang, Wenbin Huang, Zhuan Hong, Guansong Wang, Meiyu Fang, Yong Fang, Xixu Zhu, Kaiqi Du, Jiansong Ji, Yi Shen, Yiping Zhang, Shenglin Ma, Yong Song, Yuanzhi Lu, Anwen Liu, Wenfeng Fang, Wenzhao Zhong
  • Chinese Academy of Sciences
  • Nanjing University
  • Central South University
  • Affiliated Hospital of Nanjing University of Chinese Medicine
  • Shanghai Jiao Tong University
  • Tianjin Medical University
  • Jilin Cancer Hospital
  • Zhejiang University School of Medicine
  • Sun Yat-Sen University Cancer Center
  • The Second Affiliated Hospital of Zhejiang University School of Medicine
  • Yangzhou University
  • Fujian Medical University
  • Harbin Medical University
  • Renmin Hospital of Wuhan University
  • University of Chinese Academy of Sciences
  • Wenzhou Medical University
  • Capital Medical University
  • Peking University
  • The First Affiliated Hospital of Guanzhou Medical University
  • Shanxi Bethune Hospital
  • The First Affiliated Hospital of Xi’an Jiaotong University
  • Huazhong University of Science and Technology
  • Xiamen University
  • University of Electronic Science and Technology of China
  • Fudan University
  • The First Affiliated Hospital with Nanjing Medical University
  • Jiaxing University
  • Ltd.
  • Baotou Cancer Hospital
  • Nanchang University
  • Anhui Medical University
  • Sun Yat-Sen University
  • Zhejiang University
  • Lishui Central Hospital
  • Xi'an Jiaotong University
  • Jilin University
  • General Hospital of People's Liberation Army
  • The Affiliated Jiangning Hospital of Nanjing Medical University
  • The 901 Hospital of Joint Logistics Support Force of People Liberation Army
  • Zhebei Mingzhou Hospital
  • Guangdong Academy of Medical Sciences
  • Xuzhou Medical University
  • Zhejiang University School of Medicine
  • Hebei Medical University
  • Zhejiang Queue Hospital
  • Guilin Medical College
  • Zhengzhou University
  • Henan University of Science and Technology
  • Jiangsu Institute of Cancer Institute & Hospital
  • Army Medical University
  • Sir Run Run Shaw Hospital
  • The First Affiliated Hospital of Jinan University

科研成果: 期刊稿件文章同行评审

32 引用 (Scopus)

摘要

Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. The incidence of TETs is about 3.93/10000 in China, slightly higher than that of European and American countries. For resectable TETs, complete surgical resection is recommended. Radiotherapy or chemotherapy may be used as postoperative adjuvant treatment. Treatment for advanced, unresectable TETs consist mainly of radiotherapy and chemotherapy, but there is a lack of standard first- and second-line treatment regimens. Recently, targeted therapies and immune checkpoint inhibitors have shown promising outcomes in TETs. Based on the currently available clinical evidences and the opinions of the national experts, the Thymic Oncology Group of Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) established this Chinese expert consensus on the clinical diagnosis and treatment of TETs, covering the epidemiology, diagnosis, treatment, prognosis and follow-up of TETs.

源语言英语
页(从-至)1102-1117
页数16
期刊Thoracic Cancer
14
12
DOI
出版状态已出版 - 4月 2023
已对外发布

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors' 的科研主题。它们共同构成独一无二的学术指纹。

引用此